I-2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC)

Inkcazelo emfutshane:

Igama leKhemikhali: 2-Chloro-5-Iodobenzoic Acid

CAS: 19094-56-5

Uvavanyo: ≥99.0% (HPLC)

Imbonakalo: IiCrystals eziMhlophe okanye eziMthubi

Umbindi we-Empagliflozin (CAS: 864070-44-0) kunyango lwe-2 yeswekile

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Iipropati zeMichiza:

Igama leMchiza	I-2-Chloro-5-Iodobenzoic Acid
Inombolo yeCAS	19094-56-5
Inombolo yeCAT	RF-PI438
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C7H4ClIO2
Ubunzima beMolekyuli	282.46
Ukunyibilika	Inyibilika kwiMethanol
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	IiCrystals eziMhlophe okanye eziMthubi
Indlela yoVavanyo / yoHlahlelo	≥99.0% (HPLC)
Indawo yokunyibilika	161.0 ~ 163.0℃
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.20%
Ukungcola ngokupheleleyo	≤1.0%
Iintsimbi ezinzima	≤20ppm
Intsalela yokunyibilika	I-Ethanol
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi weMpagliflozin (CAS: 864070-44-0)

I-2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Indlela yokwenziwa

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-2-Chloro-5-Iodobenzoic Acid (i-CAS: 19094-56-5) ingasetyenziswa njenge-pharmaceutical intermediate kwi-synthesis ye-Empagliflozin (CAS: 864070-44-0).I-Empagliflozin (igama lorhwebo iJardiance) sisithinteli se-sodium glucose co-transporter-2 (SGLT-2), kwaye ibangela iswekile esegazini ukuba ikhutshelwe zizintso kwaye ikhutshwe kumchamo.Ngo-Agasti 1, i-2014, i-Food and Drug Administration (FDA) ivume ngokusemthethweni ichiza lonyango lwe-2 yesifo sikashukela, ukuphucula nokulawula i-glucose yegazi yabantu abadala.I-Empagliflozin lichiza lesithathu le-SGLT-2 elithintelayo elivunywe yi-FDA.Amanye amachiza amabini e-SGLT-2 inhibitor, i-Canagliflozin kunye ne-Dapagliflozin, eye-Johnson Pharmaceuticals, i-AstraZeneca kunye ne-Bristol-Myers Squibb ngokulandelanayo, ivunywe yi-FDA ngoNovemba 2013 kunye noJanuwari 2014 ngokulandelelanayo.